Breast-Conserving Surgery in Locally Advanced Breast Cancer

By Dr Raman Narang, Consultant Medical & Hemato-Oncologist

Can the breast be preserved in locally advanced breast cancer? Yes, in selected patients. Treatment before surgery can shrink the cancer enough to make breast-conserving surgery feasible. The team must still be able to identify and remove the affected area with clear margins and plan radiotherapy. Mastectomy remains the standard surgery for inflammatory breast cancer and is often preferred when disease is too extensive for a satisfactory breast-conserving operation.

Breast-Conserving Surgery in Locally Advanced Breast Cancer

A common question at the first consultation is, “Will I have to lose my breast?” Sometimes the team can answer that at diagnosis. In other cases, it can explain the likely options and agree on when to reassess. That distinction matters because the treatment given before surgery can change what is surgically possible.

What does locally advanced breast cancer mean?

Locally advanced breast cancer generally includes some stage IIB and stage III cancers. The tumour may be large relative to the breast, involve the skin or chest wall, or affect regional lymph nodes. Regional lymph nodes can include nodes under the arm or near the collarbone. When staging shows disease confined to the breast and regional areas, the treatment plan is often made with the aim of cure. It commonly combines systemic treatment, surgery and radiotherapy.

Two people with stage III breast cancer may have very different surgical options. One may have a breast tumour in a single area with substantial lymph node involvement. Another may have extensive disease across the breast or involvement of the skin. The stage helps frame treatment, while the pattern of disease helps determine the operation.

Why is treatment often given before surgery?

Treatment given before surgery is called neoadjuvant treatment. It commonly includes chemotherapy. Depending on the tumour’s biology and the clinical setting, the plan may include HER2-targeted treatment, immunotherapy or, in selected cases, endocrine therapy. The biopsy and staging findings guide the choice.

Neoadjuvant treatment can make an operation feasible and, in some patients, allow a smaller breast operation. It also lets the team see how the tumour responds. The amount of cancer remaining in the breast and lymph nodes at surgery can influence the treatment recommended afterwards.

If breast conservation may be feasible, ask whether the tumour should be marked with a small clip before treatment. A tumour can shrink substantially or become difficult to see on imaging. A marker helps the surgeon locate the original site when planning the operation. The team also needs the baseline examination and imaging to understand where disease was present before treatment.

When can breast-conserving surgery be considered?

Breast-conserving surgery, also called lumpectomy or wide local excision, removes the affected tissue and a rim of surrounding tissue while preserving most of the breast. After neoadjuvant treatment, the surgeon reviews the pretreatment findings alongside the latest examination and imaging. A smaller residual tumour helps when the affected area can be reliably located and removed with clear margins and an acceptable breast shape. In selected cases, oncoplastic techniques can facilitate a wider excision by reshaping the remaining breast tissue.

A clear margin means the pathologist finds no cancer at the relevant cut edge of the removed tissue. The final pathology report tells the team whether that goal was achieved. If cancer is found at a margin, another excision or a mastectomy may be recommended. Radiotherapy is normally part of breast-conserving treatment. The radiation oncologist also assesses whether regional lymph nodes need treatment.

When is mastectomy the better surgical choice?

Mastectomy removes the breast. It may be recommended when disease remains extensive, when the affected areas are too widely distributed for a satisfactory excision, or when the team judges that clear margins are unlikely with conservation. Persistent involvement of skin or the chest wall can also influence the operation. In stage III inflammatory breast cancer, modified radical mastectomy followed by radiotherapy remains standard after initial systemic treatment, even when the breast looks and feels much better.

Some patients choose mastectomy even when conservation is feasible. Personal preference, hereditary risk and reconstruction options can shape that choice. If postmastectomy radiotherapy is likely, discuss how it could affect reconstruction and its timing before deciding on surgery.

How do the two approaches compare?

QuestionBreast-conserving surgeryMastectomy
What is removed?The affected area and surrounding tissue, with most of the breast preservedThe breast, with reconstruction discussed where appropriate
What happens if the margins are involved?A further excision or mastectomy may be neededFurther care depends on the site of the involved margin and the overall findings
Will I need radiotherapy?Usually yes. The team also assesses whether to treat regional nodesIt may still be recommended, depending on the original extent and findings at surgery
What about lymph node surgery?Planned according to the nodes at diagnosis, treatment response and surgical findingsAlso planned according to the nodes at diagnosis, treatment response and surgical findings

The strongest randomized evidence for similar survival with breast conservation plus radiotherapy and mastectomy comes from earlier-stage breast cancer. For locally advanced disease after neoadjuvant treatment, comparisons are more dependent on which patients were offered conservation in the first place. A patient whose tumour responds well and can be removed with clear margins may have a different outlook from someone with extensive residual disease. For an individual patient, the practical question is whether both operations are oncologically appropriate after reviewing the same baseline and post-treatment findings.

What I look for clinically

I want the breast surgeon and radiation oncologist to see the pretreatment disease map as well as the latest scan. I look at where the cancer started, whether it was concentrated in one area, what the skin and lymph nodes looked like, and how uniformly the disease responded. Two patients can have the same residual tumour measurement but need different operations because their cancers were distributed differently at diagnosis.

I also ask what radiotherapy would involve with either operation. For a patient travelling into Delhi for treatment, that discussion helps the family plan where radiation can be delivered and what travel and work arrangements they may need. The operation, radiation plan and patient’s preferences belong in the same conversation.

How the decision can change after treatment

  • If the cancer is non-inflammatory and the affected area can be located and removed with clear margins while preserving an acceptable breast shape, then discuss breast-conserving surgery and radiotherapy.
  • If the remaining disease is too extensive for a satisfactory excision, then discuss mastectomy, the likelihood of radiotherapy and reconstruction options where appropriate.
  • If the diagnosis is stage III inflammatory breast cancer, then the standard plan generally includes systemic treatment first, followed by modified radical mastectomy and radiotherapy.

Questions to take to your surgical consultation

  1. Where was the cancer in the breast and lymph nodes before treatment?
  2. Was the original breast tumour marked, and can the area still be located?
  3. After treatment, am I a candidate for both operations? What finding determines that?
  4. If I choose breast conservation, what would happen if the margins are involved?
  5. What lymph node surgery would I need with either breast operation?
  6. What radiotherapy would I need after each option, and where could I receive it?
  7. Would hereditary risk assessment, oncoplastic surgery or reconstruction change my choices?

Frequently asked questions

If the tumour disappears on the scan, do I still need surgery?
Surgery remains part of standard treatment. A scan can show an excellent response, while examination of tissue under the microscope determines whether cancer cells remain.

Do positive lymph nodes automatically mean I need a mastectomy?
Lymph node involvement affects staging, underarm surgery and radiotherapy. The choice of breast operation also depends on the extent of disease in the breast and whether clear margins are achievable.

Can I avoid radiation by choosing mastectomy?
Radiotherapy can still be indicated after mastectomy. The recommendation takes into account the extent of disease at diagnosis and findings after neoadjuvant treatment, including whether lymph nodes still contain cancer.

When should I ask whether the breast can be preserved?
Ask before treatment starts so the team can review the baseline imaging and consider marking the tumour. Ask again when the team reassesses the response and can discuss the operation in detail.

When both operations are reasonable, ask the team to explain what each would mean for margins, the chance of another operation, radiotherapy and recovery. That gives you a concrete basis for choosing a treatment plan you understand.

This article is for education. Individual recommendations require review of your examination, imaging, biopsy and treatment response by your breast cancer team.

Related reads

National Cancer Institute. Treatment of Breast Cancer by Stage

Post mastectomy radiation

Breast cancer treatment

Linkedin

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top